Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactoferrin + Oral Iron in CKD Patients with Iron Deficiency Anemia
NCT05900635Phase 4Unknown
- Sponsor
- Alexandria University
- Start
- Oct 2022
- Primary completion
- Jun 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of lactoferrin in anemia of chronic kidney disease (CKD-A), sponsored by Alexandria University. Status: unknown.
02
Drugs
lactoferrin
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT05900635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05900635.